Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.

Related Posts

Leave a Reply

Recent Articles

Nobel Peace Prize bets on Polymarket under scrutiny: Report
October 14, 2025
Binance airdrops $45M in BNB to memecoin traders hit by market crash
October 14, 2025
California governor signs laws establishing safeguards over AI chatbots
October 14, 2025

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Post Category